Megamox-Es 600 mg 100 ml

Product description: Amoxicillin 600 mg in 5 ml, potassium clavulanate 42.9 mg in 5 ml: Amoxicillin 600 mg in 5 ml, powder of clavulanate potassium 42.9 mg for oral suspension, does not contain the same amount of clavulanic acid (like potassium salt) as any other Megamox suspensions. Amoxicillin 600 mg in 5 ml, powder of clavulanic potassium for oral suspension contains 42.9 mg of clavulanic acid per 5 ml. Therefore, the 200 mg / 28.5 mg / 5 ml and 400 mg / 57 mg / 5 ml Megamox suspensions should not be replaced with Amoxicillin 600 mg IN 5ML, clavulanic potassium powder for oral suspension because they are not interchangeable. Usage instructions: children aged 3 months and above: based on the amoxicillin component (600 mg / 5 ml), the recommended dose of Amoxicillin 600 mg in 5 ml, and powder of clavulanic potassium for oral suspension is 90 mg / kg / day divided every 12 hours. Instructions for mixing the oral suspension: prepare the suspension as follows: press the bottle until the powder flows freely. add about 2/3 of the total water for reconstitution and shake vigorously to suspend the powder. add the remaining water and shake vigorously again. Amoxicillin 600 mg in 5 ml, powder of clavulanic potassium 42.9 mg for oral suspension. amount of water required for reconstitution: 75 ml, 70 ml, 125 ml, 110 ml, 200 ml, 180 ml. each teaspoon (5 ml) contains 600 mg of amoxicillin as trihydrate and 42.9 mg of clavulanic acid as potassium salt. note: shake the oral suspension well before use. warnings and precautions: these reactions are more likely to occur in individuals with a history of hypersensitivity to penicillin and/or a history of multiple allergies. there have been reports of individuals with a history of hypersensitivity to penicillin experiencing severe reactions when treated with cephalosporins. before starting treatment with Megamox ES 600 mg, a thorough inquiry about previous hypersensitivity reactions to penicillin, cephalosporins, or other allergens should be conducted. in case of an allergic reaction, Megamox ES 600 mg should be discontinued and appropriate treatment initiated. severe allergic reactions require emergency treatment with adrenaline. oxygen, intravenous steroids, and airway management, including intubation, may also be necessary. since Megamox ES 600 mg contains amoxicillin, an aminopenicillin, it is not the preferred treatment for patients with sore throat or pharyngitis because the primary cause may be infectious mononucleosis, which has a high incidence of rash when using amoxicillin. Megamox ES 600 mg should be avoided if infectious mononucleosis is suspected. changes in liver function tests have been observed in some patients receiving it. liver function should be monitored regularly. transient hepatitis and cholestatic jaundice have been reported. Megamox ES 600 mg should be used with caution in patients with evidence of liver impairment. in patients with moderate or severe renal impairment, the dose should be adjusted according to the degree of impairment. ingredients: Amoxicillin 600 mg in 5 ml, clavulanic potassium 42.9 mg in 5 ml. product details: brand: Megamox, quantity: one tablet, product type: suspension, product form: suspension.